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Duration of diabetesAbstract Background: The effect of type 1 diabetes mellitus (T1DM) on myocardial function is
still controversial.
Aim: To examine the usefulness of speckle tracking echocardiography (STE) in detecting subclin-
ical left ventricular (LV) dysfunction in asymptomatic T1DM patients and detect whether any LV
abnormalities are related to duration or control of DM.
Methods: Sixty young T1DM patients and 30 controls were subjected to conventional echocardio-
graphy and STE. The left ventricular (LV) peak systolic (PS) global longitudinal strain (GLS)/strain
rate (GLSR) and diastolic global strain rate during the isovolumic relaxation period (GSRivr), early
diastole (GSRe) and late diastole (GSRa) were calculated as the average of the 12 myocardial seg-
ments of the four and two-chamber views while the mid circumferential strain (MCS) was calculated
as the average of strains of the 6 LV segments of the mid LV cavity.
Results: In diabetic patients, the LV end diastolic dimension (LVEDD) was significantly lower
(p= 0.000) while the LV myocardial performance index (LVMPI) and E/lateral E0 ratio were sig-
nificantly higher (p= 0.000 and p= 0.02 respectively) compared to controls. By STE, only the
GLS was significantly lower in diabetic patients compared to controls (p= 0.000). A significantain rate;
ain rate
density
ension;
ellitus;
ail.com
218 S.W.G. Bakhoum et al.negative correlation was detected between LDL-C and GLS (r= 0.4; p= 0.002). Multivariate
logistic regression analysis identified HbA1c as the only independent predictor of GLS in patients
(beta = 0.34, 95% CI: 0.67 to 0.19; p= 0.001).
Conclusion: STE is useful to detect subclinical LV dysfunction in asymptomatic patients with
T1DM. Control of DM but not duration of disease was an independent predictor of LV systolic
dysfunction.
 2016 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Type 1 diabetes mellitus (T1DM) is potentially associated with
serious microvascular and macrovascular complications,
although these are usually subclinical during the pediatric and
adolescent years. The duration of diabetes, glycemic control,
age, and pubertal stage are critical factors contributing toward
development of such complications.1,2 T1DM is associated with
at least 10-fold increase in cardiovascular disease as compared
with an age matched non-diabetic population.3,4 Diabetes does
not only result in abnormalities of the vasculature but also
induces structural and functional abnormalities of the myo-
cardium ‘‘diabetic cardiomyopathy”.5–7 The incidence of
diabetic cardiomyopathy in the absence of coronary artery dis-
ease (CAD) or systemic hypertension (HTN) in T1DM however,
is still controversial. Asymptomatic children and adolescents
with T1DM showed evidence of subclinical right ventricle
(RV) and left ventricle (LV) diastolic dysfunction that correlated
with the degree of insulin resistance, duration of DM, and meta-
bolic control.8,9 Cardiac magnetic resonance performed on
T1DM patients of the mega study Diabetes Control and
Complications Trial/Epidemiology of Diabetes Interventions
and Complications (DCCT/EDIC) revealed that macro-
albuminuria and mean glycosylated hemoglobin (HbA1c) were
significantly associated with myocardial scar and alterations of
LV structure and function.10,11 In contrast to these results, a
study of patients with long duration (>10 years) T1DM
revealed no significant differences in echocardiographic diastolic
or systolic LV function indices or serum level of N-terminal pro-
B type natriuretic peptide (NT-pro BNP) between patients and
non-diabetic controls despite histological changes typical of dia-
betes detected in hearts of some of the study deceased patients.12
Speckle tracking echocardiography (STE) has emerged as an
accurate quantitative technique to assess global and regional
myocardial deformation parameters, being independent of both
cardiac translation and insonation angle.13,14 The assessment of
myocardial deformation allows early detection of subclinical LV
systolic and diastolic dysfunction in different cardiac diseases.15–17
The aim of this study was to examine the usefulness of two-
dimensional STE in detecting subclinical LV dysfunction in
asymptomatic T1DM patients before overt clinical diabetic
cardiomyopathy ensues and to detect whether any detected
LV abnormalities are related to duration or control of DM.
2. Methods
2.1. Study population
We included in the study 60 asymptomatic T1DM patients
without known cardiovascular disease, have never smokedand with an LV ejection fraction >55% by biplane Simpson’s
method. T1DM was defined as being diagnosed in patients
before the age of 30, and treated by insulin from the beginning
of treatment.18 We excluded patients with hypertension
defined as blood pressure P140/90, CAD, moderate to severe
valvular heart disease, congenital heart disease and atrial fibril-
lation or other severe arrhythmias. The patients were recruited
from those admitted in the National Institute of Diabetes and
Endocrinology. The control group comprised 30 age and sex-
matched, healthy non-diabetic, normotensive and never smo-
ker subjects with no other comorbid conditions.
2.2. Methods
2.2.1. Clinical evaluation
All the patients and controls were subjected to full history tak-
ing, clinical examination and measurement of weight and
height to calculate the body mass index (BMI). The BMI
was calculated by the formula: BMI = weight in kilograms/
(height in meters).2 Waist circumference (WC) was measured
with a non-elastic tape at the mid distance between the top
of the iliac crest and the bottom of the rib cage and as the aver-
age of one measurement taken after inspiration and one taken
after expiration.
2.2.2. Laboratory investigations
A 14-h fasting peripheral venous blood sample was taken from
patients and controls in order to measure total cholesterol
(TC), high density lipoprotein cholesterol (HDL-C), and
triglycerides (TG). Low density lipoprotein cholesterol (LDL-C)
was estimated using the Friedwald formula [LDL-C=TC
(HDL-C + TG/5)] if the TG were <400 mg/dl.19 If the TG
were P400 mg/dl, the LDL-C was directly determined. An
8-h peripheral venous blood sample was also taken in another
day from all patients in order to measure fasting blood sugar
(FBS). Serum urea, creatinine, HbA1c, and albumin creatinine
(A/C) ratio in urine were also measured.
2.2.3. Conventional echocardiography and tissue Doppler
imaging
All echocardiographic examinations were obtained using
Mylab 60 XVision machine (Esaote, Italy) and performed
according to the recommendations of American Society of
Echocardiography.20 The left atrium and aortic root dimen-
sions were measured in the left parasternal long axis view. Left
ventricular diameters and wall thicknesses were measured in
the left parasternal long axis view at the level of the mitral
valve tips, ensuring a measurement perpendicular to the long
axis of the ventricle. Pulsed wave Doppler was used to record
trans-mitral flow at the tips of the mitral leaflets in the
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flow in the five-chamber (5-CH) apical view. Peak velocity of
early (E) and late atrial (A) diastolic filling of the Doppler
mitral flow, E/A ratio and E wave deceleration time (E-DT)
were calculated. LVEF was determined using modified biplane
Simpson’s method in the 4-CH and the two-chamber (2-CH)
apical views. The tissue Doppler imaging (TDI) was performed
using transducer frequencies of 3.5–4.0 MHZ, adjusting the
spectral pulsed Doppler signal filters to obtain the Nyquist
limit of 15 and 20 cm/s, and using the minimal optimal gain
to minimize noise. TDI was recorded at 100 mm/s sweep
speed. Meticulous care was taken to align the echocardio-
graphic image to place the annular motion parallel to the
TDI cursor (angle <15). In the apical 4-CH view, a 5 mm
Doppler sample volume was placed at the lateral border of
the mitral annulus. From the TDI tracing, the following mea-
surements were obtained:
 Peak diastolic velocity during early filling (E0), late filling
(A0) and peak systolic velocity (S).
 Ratio between peak diastolic velocities of lateral annulus E0
and A0 waves or E0/A0 ratio.
 Isovolumic contraction time (IVCT) measured as the time
interval between the end of late diastolic A0 wave and the
onset of the systolic S wave.
 Isovolumic relaxation time (IVRT) measured as the time
interval between the end of the systolic S wave and the onset
of the early diastolic E0 wave.
 Ejection time (ET) measured as the time interval between
the onset and the end of the S wave.
 Left ventricular myocardial performance index (MPI) was
calculated according to the formula: MPI = IVRT
+ IVCT/ET.
 Doppler trans-mitral peak E wave velocity/tissue Doppler
lateral mitral annulus peak E0 wave velocity ratio (E/E0
ratio).2.2.4. Speckle tracking echocardiography
STE was used to measure different LV deformation parame-
ters according to the recommendations of the American Soci-
ety of Echocardiography.21 The machine ‘Esaote Mylab 60
Xvision’ we used in the current study uses a specific technology
‘velocity vector imaging’ to track the grayscale image speckles.
Three consecutive end-expiratory cardiac cycles using high
frame rate >80 s1 harmonic imaging were acquired in the
apical 4-CH, 2-CH and the short-axis (SAX) mid-ventricular
view at the level of the papillary muscles. The STE analysis
was performed offline on grayscale images of the LV obtained
in these views. The analysis was initiated by defining manually
in the apical views three endocardial landmarks at the lateral
and medial corners of the mitral annulus and the LV cardiac
apex and in the mid ventricular SAX view, two landmarks at
the inferior septum and the lateral wall. Thereafter, the endo-
cardium and epicardium were delineated and the region of
interest was divided into 6 segments automatically by the
machine software. Manual adjustment of the segments of
interest was performed when necessary. Once the regions of
interest were optimized, the software generates automatically
strain curves for different myocardial segments. From the api-
cal 4-CH view, longitudinal strain/strain rate (LS/LSR) wasassessed through basal, mid, apical inferior septal and basal,
mid and apical antero-lateral wall segments. From the apical
2-CH view, LS/LSR was assessed through basal, mid, apical
inferior wall and basal, mid, and apical anterior wall segments.
The peak systolic (PS) global longitudinal strain/strain rate
(GLS/GLSR) was calculated as the average of the LS/LSR
of the 12 myocardial segments of the 4-CH and 2-CH views.
The global peak diastolic SR during the isovolumic relaxation
period (GSRivr), early diastole (GSRe) and late diastole
(GSRa) was also calculated as the average of the SR of the
12 myocardial segments of the 4-CH and 2-CH views. From the
short axis view at the level of the papillary muscles, the circum-
ferential strain (CS) was assessed through the mid-segments
of the antero-septal, anterior, antero-lateral, infero-lateral,
inferior, and infero-septal walls. The PS mid circumferential
strain (MCS) was calculated as the average of strains of the
6 LV segments of the mid LV cavity short axis view.
3. Statistical analysis
Normally distributed continuous variables were expressed as
mean ± standard deviation (SD) while continuous variables
with non-normal distribution were presented as median values
and interquartile range (IQR). Categorical data were expressed
as percentages. Differences between groups were assessed by
unpaired 2-tailed t test and the Mann–Whitney U test for con-
tinuous variables, according to whether they were normally
distributed or not. Categorical data and proportions were ana-
lyzed by the use of chi-square or Fisher’s exact test when
required. Correlations were sought using the Spearman and
Pearson correlation analyses where appropriate to determine
correlation between different demographic, clinical and STE
parameters. Univariate and multivariable linear regression
analysis was used to investigate possible association between
different clinical, laboratory, conventional echocardiographic,
TDI parameters and STE LV deformation parameters in
patients. All analyses were performed using SPSS software
(SPSS system for Windows, version 20. Inc. Headquarters.
Chicago, IL).
4. Results
4.1. Demographic and clinical data
The mean age of the patients was 21.08 ± 5.7 years. The mean
duration of the disease was 9.5 ± 6.66 years. The patients had
significantly lower weight, height, WC, and BMI compared to
control subjects (p= 0.001, p= 0.001, p= 0.002 and
p= 0.000 respectively). There was no statistically significant
difference between patients and control subjects as regards
age, gender, systolic or diastolic blood pressure (Table 1).
4.2. Laboratory data
The patients had significantly higher FBS, HbA1c, HDL-C
and A/C ratio in urine compared to control subjects
(p= 0.000, p= 0.000, p= 0.01 and p= 0.000 respectively).
There was no statistically significant difference between
patients and control subjects as regards serum urea, creatinine,
TC, LDL-C and TG (Table 2). Thirty three (55%) out of 60
Table 1 Demographic and clinical data of patients and control subjects.
Variable Patients (N= 60) Control subjects (N= 30) P value
Age (years) 21.08 ± 5.7 23.60 ± 6.62 0.066
Gender (M/F) 28/32 17/13 0.5
Weight (Kg) 60.88 ± 11.05 73.02 ± 13.26 0.001
Height (cm) 162.99 ± 7.70 168.32 ± 7.0 0.001
BMI (Kg/m2) 22.87 ± 3.80 25.68 ± 3.83 0.000
WC (cm) 80.95 ± 8.06 86.55 ± 9.6 0.002
SBP (mmHg) 120.50 ± 15.72 120.23 ± 7.23 0.95
DBP (mmHg) 77.33 ± 4.91 76.82 ± 5.61 0.62
M: males. F: females. BMI: body mass index. WC: waist circumference. SBP: systolic blood pressure. DBP: diastolic blood pressure.
220 S.W.G. Bakhoum et al.patients had no albuminuria. The remaining patients had
micro or macro-albuminuria.
4.3. Conventional echocardiography and tissue Doppler imaging
data
The patients had significantly lower aortic root dimensions
and left ventricular end diastolic dimensions (LVEDD) com-
pared to control subjects (both p= 0.000). There was no sta-
tistically significant difference between patients and control
subjects as regards left ventricular end systolic dimensions
(LVESD), interventricular septal thickness, posterior wall
thickness, LV fractional shortening percent (FS%) or LV ejec-
tion fraction percent (EF%).
The patients had significantly higher Doppler trans-mitral
peak A wave velocity and significantly lower E-DT compared
to control subjects (p= 0.003 and p= 0.000 respectively).
There was no statistically significant difference between
patients and control subjects as regards trans-mitral peak E
wave velocity and E/A ratio.
The patients had significantly higher tissue Doppler (TD)
derived IVRT, IVCT, MPI and significantly lower ET com-
pared to control subjects (all p= 0.000). The patients had sig-
nificantly higher E/E0 ratio compared to control subjects
(p= 0.017). There was no statistically significant difference
between patients and control subjects as regards mitral lateral
annulus E0, A0, S wave peak velocities or E0/A0 ratio (Table 3).
4.4. Speckle tracking echocardiography data
The patients had significantly lower GLS compared to control
subjects (p= 0.000). There was no statistically significantTable 2 Laboratory data of patients and control subjects.
Variable Patients (N= 60)
FBG (mg/dl) 260.52 ± 68.65
Urea (mg/dl) 19.25 ± 8.31
Creatinine (mg/dl) 1.18 ± 2.75
TC (mg/dl) 198.73 ± 47.26
LDL-C (mg/dl) 107.92 ± 42.90
HDL-C (mg/dl) 61.75 ± 26.88
TG (mg/dl) 135.38 ± 90.15
A/C ratio (mg/gm) 184.26 ± 400.02
HbA1c (%) 9.77 ± 1.43
FBS: fasting blood sugar. TC: total cholesterol. LDL-C: low density lipop
triglycerides. A/C: albumin/creatinine. HbA1c: glycosylated hemoglobin.difference between patients and control subjects as regards
GLSR, MCS, GSRivr, GSRe and GSRa (Table 4) (Figs. 1–3).
4.5. Correlation analysis
Pearson correlation analysis was used to detect possible corre-
lation between disease duration, TC, LDL-C, HDL-C, urinary
albumin/creatinine ratio, HbA1c, LVEDD, peak A wave
velocity, LV MPI, E/lateral E0 ratio and GLS in patients. A
significant negative correlation was detected between LDL-C
and GLS (r= 0.4; p= 0.002). Multivariable logistic regres-
sion analysis identified HbA1c as the only independent predic-
tor of GLS in patients (beta = 0.34, 95% CI: 0.67 to
0.19; p= 0.001).
Again, no significant correlation could be detected between
duration of the disease or HbA1c and IVRT, E/lateral E0 or
LV MPI.
5. Discussion
In this study, we have demonstrated subclinical impairment of
diastolic and systolic global LV function in young asymp-
tomatic T1DM patients without evident cardiovascular dis-
ease. We also identified glycemic control as the only
independent predictor of peak systolic GLS which was signif-
icantly reduced in diabetic patients compared to controls.
The patients with T1DM in our study had significantly
lower weight, height, WC, and BMI compared to control sub-
jects. This can be explained by the catabolic effect of DM in
these young patients with poor glycemic control (mean HbA1c
was 9.77 ± 1.42) and in whom diet control is usually diffi-
cult.22 The patients had significantly lower aortic rootControl subjects (N= 30) P value
79.55 ± 9.53 0.000
18.36 ± 6.20 0.52
0.70 ± 0.128 0.41
180.18 ± 44.36 0.07
104.41 ± 41.26 0.09
52.14 ± 11.96 0.01
116.82 ± 58.45 0.42
11.27 ± 1.78 0.000
5.25 ± 0.16 0.000
rotein cholesterol. HDL-C: high density lipoprotein cholesterol. TG:
Table 3 Conventional echocardiography and tissue Doppler
imaging data of patients and control subjects.
Variable Patients
(N= 60)
Control
subjects
(N= 30)
P value
Conventional echocardiography
LA (cm) 3.07 ± 0.43 3.09 ± 0.47 0.78
AO (cm) 2.29 ± 0.294 2.59 ± 0.418 0.000
LVEDD (cm) 4.39 ± 0.50 4.76 ± 0.38 0.000
LVESD (cm) 2.855 ± 0.53 2.99 ± 0.48 0.42
IVST (cm) 0.751 ± 0.124 0.71 ± 0.15 0.38
PWT (cm) 0.716 ± 0.11 0.73 ± 0.16 0.64
FS (%) 38.87 ± 25.71 35.73 ± 4.59 0.23
LVEF (%) 64.72 ± 8.03 64.77 ± 6.09 0.76
Peak E velocity (cm/s) 87.8 ± 23.87 81.64 ± 16.95 0.34
Peak A velocity (cm/s) 64.27 ± 14.1 56.05 ± 9.95 0.003
E/A ratio 1.46 ± 0.47 1.47 ± 0.2 0.64
E–DT (ms) 144.18 ± 32.87 173 ± 14.07 0.000
Tissue doppler imaging
IVRT (ms) 75.37 ± 19.06 56.59 ± 5.97 0.000
IVCT (ms) 67.97 ± 17.34 56.32 ± 7.81 0.000
ET (ms) 251.32 ± 36.76 282.82 ± 22.34 0.000
MPI 0.58 ± 0.18 0.39 ± 0.04 0.000
LateralaE0 (cm/s) 17.5 ± 3.7 18.61 ± 4.1 0.79
Lateral A0 (cm/s) 9.75 ± 3.36 10.14 ± 2.23 0.12
E0/A0 ratio 1.76 ± 0.55 1.94 ± 0.68 0.13
Lateral S (cm/s) 13.0 ± 4.38 12.61 ± 2.36 0.27
E/lateral E0 ratio 5.14 ± 1.52 4.52 ± 0.89 0.02
LA: left atrium. Ao: aorta. LVEDD: left ventricular end diastolic
dimensions. LVESD: left ventricularend systolic dimensions. IVST:
interventricular septal thickness. PWT: posterior wall thickness.
FS: fractional shortening. LVEF: left ventricular ejection fraction.
E-DT: E deceleration time. IVRT: isovolumic relaxation time.
IVCT: isovolumic contraction time. ET: ejection time. MPI:
myocardial performance index.
a Lateral mitral annulus.
Table 4 Speckle tracking echocardiography data of patients
and control subjects.
Variable Patients
(N= 60)
Control subjects
(N= 30)
P value
GLS (%) 16.87 ± 3.41 19.2 ± 2.02 0.000
MCS (%) 23.08 ± 6.28 24.56 ± 5.18 0.20
GLSR (1/s) 1.09 ± 0.30 1.01 ± 0.13 0.078
GSRivr (1/s) 0.16 ± 0.06 0.18 ± 0.09 0.6
GSRe (1/s) 1.41 ± 0.45 1.35 ± 0.52 0.53
GSRa (1/s) 0.65 ± 0.29 0.55 ± 0.22 0.20
GLS: global longitudinal strain. MCS: mean circumferential strain.
GLSR: global longitudinal strain rate. GSRivr: global strain rate
during isovolumic relaxation period. GSRe: global strain rate
during early diastole. GSRa: global strain rate during late diastole.
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lower LV dimensions could be related to the smaller body sur-
face area of these patients who had significantly lower height
and weight compared to control subjects.The patients in the current study had serum TC, LDL-C
and TG similar to controls but significantly higher HDL-C
compared to controls. A study by Dabas et al.23 reported a
normal serum TC, LDL-C, HDL-C and TG in adolescents
with T1DM despite a poorly controlled diabetes (mean
HbA1c: 8.0) and there was no correlation between different
lipid parameters and LV function as assessed by conventional
echocardiography. Gull et al.24 showed no significant differ-
ence between T1DM patients and controls in terms of TC,
LDL-C, HDL-C. Although TG were significantly higher in
T1DM patients compared to controls, they were still in the
normal range. Two previous studies25,26 have shown that
HDL-C is optimum in T1 DM patients and may not be a use-
ful marker of cardiovascular disease in these patients.26
As regards indices of LV diastolic function, diabetic
patients in our study had significantly higher trans-mitral Dop-
pler peak A wave velocity, E/lateral E0 ratio and IVRT com-
pared to control subjects. These results were in agreement
with the study by Wojcik et al.8 who used conventional Dop-
pler echocardiography to demonstrate a significant prolonga-
tion of IVRT and decrease in the trans-mitral Doppler peak
E wave velocity and E/A ratio despite normal systolic LV func-
tion in T1DM pubertal patients compared to controls. In their
study, the abnormalities of diastolic function correlated with
the degree of insulin resistance and DM duration in girls,
and similarly as in boys, with the long term metabolic control
of the disease as represented by the mean HbA1c over the
entire treatment period. Using TDI, Salem et al.9 reached sim-
ilar results by demonstrating significantly lower mitral annular
E0 velocity and E0/A0 ratio which were associated with higher
HbA1c in T1DM patients compared to controls. Another
TDI study24 revealed a significantly lower septal E0, lateral
E0 and significantly higher E/septal E0 and E/lateral E0 ratios
in diabetic patients compared to controls. In this study, DM
duration and complications but not HbA1c correlated with
impaired LV diastolic parameters. A significantly increased
E/E0 ratio in TIDM patients compared to controls was also
demonstrated to correlate significantly with advanced glyca-
tion end products.27 In our study, we elected to measure the
lateral E0 velocity as it correlates better with LV filling pressure
in the setting of a normal ejection fraction.28 We could not find
however any significant correlation between DM duration or
HbA1c and trans-mitral A wave, IVRT, or E/Lateral E0 ratio
in our patients. Similarly, de Simone et al.29 showed no corre-
lation between presence of target organ damage, duration of
disease or levels of glycosylated hemoglobin and LV diastolic
abnormalities detected in T1DM patients. Discordant to our
findings, certain studies did not recognize diastolic dysfunction
in T1DM. Romanens et al.30 assessing T1DM patients
described as being free of autonomic neuropathy, major micro
or macrovascular complications and without evidence of
ischemic heart disease or hypertension, found no evidence of
diastolic dysfunction in these patients. In a study12 of T1DM
patients with long disease duration (mean duration 23 years),
none of the patients showed evidence of impaired diastolic
function despite a statistically significant difference in the pul-
monary venous S/D and the TDI E/E0 ratios between patients
and controls. There was also no significant difference in serum
level of N-terminal pro-B type natriuretic peptide between
patients and control subjects.
As regards indices of LV systolic function, diabetic patients
in our study had significantly lower LV GLS despite similar
Figure 1 Longitudinal strain of the different segments of the inferior septum and lateral wall (each segment is represented by a different
color) in the 4-Chamber view. The white line represents the average strain of the different segments.
GSRe
GSRa
GSRivr
Figure 2 Global diastolic strain rate (SR) signal (white line) in the four-chamber view. GSRe: global SR during early left ventricular
diastolic filling. GSRa: global SR during late left ventricular diastolic filling. GSRivr: global SR during isovolumic relaxation period.
222 S.W.G. Bakhoum et al.LV EF compared to controls. This finding was in agreement
with the results of several studies. A study27 of T1DM patients
without significant coronary stenosis by coronary angiography
revealed a significantly reduced LV longitudinal strain by STE.
They attributed this impaired LV longitudinal function to
myocardial microangiopathy as evidenced by a significantlylower myocardial blood flow reserve detected by contrast
echocardiography compared to controls. Abdel-Salam et al.31
demonstrated a significantly reduced GLS and GLSR in
T1DM patients compared to controls despite similar global
longitudinal early diastolic strain rate (GLSRe) in both
groups. In the present study, we could not find as well a
Figure 3 Left ventricular circumferential strain of the different segments (each segment is represented by a different color) in the short
axis view at the level of the papillary muscles. The white line represents the average strain of the different segments.
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GLSivr, GLSe or GLSa between patients and controls. A large
study32 on 1065 T1DM patients revealed a significantly
reduced GLS compared to controls. When the patients were
stratified by degrees of albuminuria, this difference was shown
to be driven solely by decreased GLS in T1DM patients with
albuminuria. T1DM patients with no albuminuria had systolic
myocardial function similar to healthy control subjects. In our
study, 45% of the patients had some degree of albuminuria.
We could not however, detect any correlation between the
urinary A/C ratio and GLS. Kim and Kim33 assessing LV
function of T1DM Korean children and adolescents, demon-
strated a reduced regional strain and strain rates at the
basal and mid septum of patients with DM duration >4 years
compared to patients with shorter disease duration. In the
current study, we could identity metabolic control of DM as
represented by HBA1c, but not diabetes duration as an
independent predictor of GLS. Hyperglycemia has been shown
to result in a dysfunctional sarcoplasmic reticulum (SR),
leading to reduced sequestration of calcium into the SR caus-
ing a prolonged cardiac relaxation, reduced systolic calcium
release and therefore a weaker cardiac contraction.34–36
Another explanation for this impaired longitudinal deforma-
tion is the effect of a diseased coronary microvasculature on
the sub-endocardial region which is most vulnerable to ische-
mia. Since longitudinal myocardial fibers predominate in the
sub-endocardial region, it is expected that longitudinal defor-
mation abnormalities are both sensitive and specific for the
early detection of subclinical LV dysfunction in these
patients.37Finally, the current study showed an impairment of LV glo-
bal function as evidenced by a significantly higher MPI in
patients compared to control subjects. A higher LV MPI was
similarly detected in the study of Salem et al.9 on T1DM chil-
dren and adolescents. This higher MPI is a reflection of signif-
icantly higher IVRT and IVCT and significantly lower ejection
time in our patients. The isovolumic contraction time corre-
sponds to when calcium enters the myoplasm from the sar-
colemma, while isovolumic relaxation time reflects the
removal of Ca2+ from the myoplasm by Ca2+-ATPases. It
seems that changes in cellular Ca2+ handling in the myocar-
dium which was found to be impaired in DM, underlie much
of the abnormal contractility and relaxation.38 MPI is an index
of combined systolic and diastolic function and was found to
provide important prognostic information for the risk of
future congestive heart failure, beyond other measurements
of cardiac function and traditional heart failure risk
factors.39,40
6. Limitations
This study has some limitations. The first is the relatively small
number of patients. The rigorous exclusion criteria that com-
prised hypertension and smoking (current or former) however
may partly explain the small number of included patients. This
relatively small number of patients did not allow us to divide
them into 2 groups with longer and shorter disease duration.
The second is not subjecting the patients to tests such as
myocardial perfusion imaging or coronary angiography to
exclude coronary affection as the underlying cause of the
224 S.W.G. Bakhoum et al.myocardial dysfunction rather than diabetic cardiomyopathy.
We speculated that the patients included in the study are
young (mean age 21.1 ± 5.7 years) and asymptomatic and
consequently the possibility of coronary affection must be
low. The third is the cross-sectional nature of the study. A
follow-up of the progression and the clinical impact of the sub-
tle LV diastolic and systolic abnormalities detected in this
study would have added important information to the devel-
opment of cardiac complications and congestive heart failure
in T1DM patients. Finally, we measured the left ventricular
(LV) global longitudinal strain (GLS) as the average of the
12 segments in the apical 4 chamber and 2 chamber views
and did not take into account the 6 segments of the apical 3
chamber view (apical long axis view). We thought that calcu-
lating the GLS in only 2 apical instead of 3 apical views would
be valid in this young population (age: 21.08 ± 5.7) with no
segmental wall motion abnormalities in the resting echocardio-
graphy and no history of coronary artery disease. We did not
think adding analysis of additional segments would signifi-
cantly change the results or affect the accuracy of the measure-
ments which were compared to control subjects using the same
methodology.
7. Conclusion
Young asymptomatic patients with T1DM have evidence of
impaired left ventricular both diastolic and systolic function
compared to control subjects. STE allowed early detection of
abnormal systolic longitudinal deformation before overt
impairment of indices of LV systolic function. The glycemic
control as detected by HbA1c was the only independent pre-
dictor of abnormal LV longitudinal function.
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